QRX003, 4% Lotion

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton SyndromeNCT05789056Quoin PharmaceuticalsPhase 2, Phase 3Recruiting2026-12-30Estimated
Clinical Study of QRX003 Lotion in Subjects With Netherton SyndromeNCT06953466Quoin PharmaceuticalsPhase 2, Phase 3Recruiting2026-12-30Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.